| Literature DB >> 34210728 |
Juliëtte J C M van Munster1,2, Joost J G Wammes3, Rolf H Bremmer3, Amir H Zamanipoor Najafabadi2, Raphael J Hemler4, Wilco C Peul2, Wilbert B van den Hout5, Peter Paul G van Benthem6.
Abstract
OBJECTIVE: In the past few decades, there has been an increase in high-quality studies providing evidence on the effectiveness of commonly performed procedures in paediatric otolaryngology. We believe that now is the time to re-evaluate the care process. We aimed to analyse (1) the regional variation in incidence and referrals of adenoidectomies, tonsillectomies and ventilation tube insertions in children in the Netherlands between 2016 and 2019, (2) whether regional surgical rates, referral rates and in-hospital surgical rates were associated with one another, and (3) the hospital variation in healthcare costs, which indicates the utilisation of resources.Entities:
Keywords: health economics; paediatric otolaryngology; protocols & guidelines; quality in health care
Year: 2021 PMID: 34210728 PMCID: PMC8252878 DOI: 10.1136/bmjopen-2020-046840
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Flow chart of patient selection. ENT, ear, nose and throat.
Baseline data of all patients aged 0–15 years visiting an ENT clinic in 2016–2019
| Non-surgical treatment (n=43 821) | Surgical treatment (n=42 587) | |
| Age*, mean (SD) | 6.2 (3.8) | 5.0 (2.9) |
| Socioeconomic status, n (%) | ||
| Low | 23 082 (53) | 22 520 (53) |
| Middle | 13 270 (31) | 12 917 (30) |
| High | 7469 (17) | 7150 (17) |
| Sex, n (%) | ||
| Male | 24 369 (56) | 23 955 (56) |
| Female | 19 452 (44) | 18 632 (44) |
| Charlson Comorbidity Index, n (%) | ||
| 0 | 41 704 (95) | 40 477 (95) |
| 1 | 2008 (5) | 2024 (5) |
| >2 | 109 (0) | 86 (0) |
| Diagnoses*, n (%) | ||
| Otitis media or tube dysfunction | 34 054 (78) | 23 087 (54) |
| Diseases of the tonsils | 9093 (21) | 14 831 (35) |
| Obstructive sleep apnoea | 80 (0) | 77 (0) |
| Multiple diagnoses | 594 (1) | 4592 (11) |
*Indicates a statistically significant difference (p<0.05) between groups.
ENT, ear, nose and throat.
Figure 2Dot plots of adjusted surgical rates per 1000 children aged 0–15 years living in the hospital service areas.
Regional variation in surgical rates and referrals from 2016 to 2019 in children aged 0–15 years in two-digit postal code areas
| Average rate | EQ | EQ5–95 | IqR | CoV | SCV | SCV5–95 | |
| Regional surgical rates per 1000 inhabitants aged 0–15 years (two-digit postal code area) | |||||||
| Adenoidectomy | |||||||
| 2016 | 1.9 | 9.5 | 2.7 | 1.8 | 0.5 | 26.3* | 4.8 |
| 2017 | 1.8 | 10.5 | 3.8 | 1.8 | 0.7 | 39.1* | 6.5† |
| 2018 | 1.8 | 7.4 | 3.4 | 2.2 | 0.5 | 16.0* | 6.9† |
| 2019 | 1.8 | 6.2 | 3.8 | 1.9 | 0.5 | 21.2* | 8.4† |
| All years | 1.8 | 7.2 | 2.6 | 1.9 | 0.5 | 23.4* | 7.3† |
| Adenotonsillectomy | |||||||
| 2016 | 7.8 | 2.1 | 1.7 | 1.2 | 0.2 | 2.2 | 0.7 |
| 2017 | 7.8 | 2.4 | 1.6 | 1.2 | 0.2 | 3.2 | 0.7 |
| 2018 | 6.9 | 2.2 | 1.8 | 1.2 | 0.2 | 4.1 | 1.3 |
| 2019 | 6.6 | 2.6 | 1.8 | 1.3 | 0.2 | 3.6 | 1.7 |
| All years | 7.3 | 2.1 | 1.5 | 1.2 | 0.2 | 2.9 | 1.1 |
| Ventilation tube insertion | |||||||
| 2016 | 13.2 | 2.3 | 1.6 | 1.3 | 0.2 | 3.3 | 1.2 |
| 2017 | 14.2 | 2.2 | 1.6 | 1.4 | 0.2 | 3.2 | 2 |
| 2018 | 13.7 | 2.2 | 1.6 | 1.3 | 0.2 | 2.9 | 1 |
| 2019 | 12.9 | 2 | 1.6 | 1.2 | 0.2 | 2.9 | 1.5 |
| All years | 13.5 | 1.9 | 1.5 | 1.3 | 0.2 | 2.8 | 1.6 |
| Referral rates per 1000 inhabitants aged 0–15 years (two-digit postal code area) | |||||||
| 2016 | 44.1 | 2.4 | 1.5 | 1.3 | 0.2 | 2.7 | 1.5 |
| 2017 | 44.5 | 2.6 | 1.5 | 1.3 | 0.2 | 3.1 | 1.5 |
| 2018 | 42.7 | 2.7 | 1.6 | 1.3 | 0.2 | 2.8 | 1.2 |
| 2019 | 41 | 2.2 | 1.5 | 1.4 | 0.2 | 2.7 | 1.6 |
| All years | 43.1 | 2.4 | 1.5 | 1.3 | 0.2 | 2.8 | 1.5 |
SCV >3=likely due to differences in practice style or ‘medical discretion’; 5–10=high variation; >10=very high variation.
*Very high variation.
†High variation.
CoV, coefficient of variation; EQ, extreme quotient; IqR, interquartile ratio; SCV, systematic component of variation.
Variation in surgical rates from 2016 to 2019 in children aged 0–15 years between hospitals and hospital service areas
| Average rate | EQ | EQ5–95 | IqR | CoV | SCV | SCV5–95 | |
| Regional surgical rates per 1000 inhabitants aged 0–15 years (hospital service areas) | |||||||
| Adenoidectomy | |||||||
| 2016 | 1.9 | 6 | 2.6 | 1.8 | 0.5 | 24.0* | 7.5† |
| 2017 | 1.8 | 8 | 3.6 | 2 | 0.6 | 28.3* | 11.7* |
| 2018 | 1.8 | 5.7 | 3.4 | 2 | 0.5 | 21.2* | 10.7* |
| 2019 | 1.8 | 5.6 | 3.6 | 1.7 | 0.5 | 18.4* | 9.6† |
| All years | 1.8 | 5.7 | 3.2 | 1.8 | 0.5 | 22.4* | 9.6† |
| Adenotonsillectomy | |||||||
| 2016 | 7.9 | 2 | 1.7 | 1.2 | 0.2 | 3 | 1.3 |
| 2017 | 7.8 | 3.4 | 1.7 | 1.1 | 0.2 | 5.1† | 1.2 |
| 2018 | 6.9 | 2.7 | 1.5 | 1.2 | 0.2 | 4.6 | 1.2 |
| 2019 | 6.6 | 2.9 | 2.3 | 1.2 | 0.3 | 6.3† | 2.9 |
| All years | 7.3 | 2.5 | 1.6 | 1.2 | 0.2 | 4.2 | 1.4 |
| Ventilation tube insertion | |||||||
| 2016 | 13.2 | 2.7 | 1.6 | 1.1 | 0.2 | 4.8 | 1.8 |
| 2017 | 14.2 | 2.7 | 1.7 | 1.2 | 0.2 | 4 | 1.5 |
| 2018 | 13.7 | 1.9 | 1.8 | 1.1 | 0.2 | 3.8 | 2.1 |
| 2019 | 12.9 | 1.9 | 1.6 | 1.2 | 0.2 | 2.9 | 1.4 |
| All years | 13.5 | 2.2 | 1.6 | 1.2 | 0.2 | 3.8 | 1.7 |
| In-hospital surgical rates per 1000 hospital visitors aged 0–15 years | |||||||
| Adenoidectomy | |||||||
| 2016 | 44 | 6.2 | 2.7 | 1.4 | 0.5 | 18.0* | 8.8† |
| 2017 | 39 | 8.1 | 3.1 | 2.3 | 0.5 | 19.4* | 10.3* |
| 2018 | 41 | 4.1 | 3.7 | 1.7 | 0.4 | 14.9* | 10.0* |
| 2019 | 43 | 7 | 2.7 | 1.5 | 0.4 | 15.9* | 5.8† |
| All years | 42 | 5.8 | 2.4 | 1.6 | 0.4 | 16.9* | 5.6† |
| Adenotonsillectomy | |||||||
| 2016 | 178 | 1.8 | 1.7 | 1.4 | 0.2 | 4.1 | 2.7 |
| 2017 | 176 | 2.9 | 1.8 | 1.3 | 0.3 | 5.8† | 3.1 |
| 2018 | 161 | 2.6 | 1.8 | 1.3 | 0.3 | 5.8† | 3.3 |
| 2019 | 160 | 2.5 | 2.2 | 1.5 | 0.3 | 7.4† | 5.1† |
| All years | 169 | 2.3 | 1.8 | 1.4 | 0.2 | 5.4† | 3.5 |
| Ventilation tube insertion | |||||||
| 2016 | 300 | 2.1 | 1.6 | 1.2 | 0.2 | 3.5 | 2 |
| 2017 | 318 | 2.2 | 1.5 | 1.2 | 0.2 | 2.8 | 1.1 |
| 2018 | 320 | 1.7 | 1.6 | 1.2 | 0.2 | 2 | 1.2 |
| 2019 | 316 | 1.7 | 1.4 | 1.2 | 0.1 | 1.7 | 1 |
| All years | 313 | 1.7 | 1.5 | 1.2 | 0.2 | 2.4 | 1.7 |
SCV >3=likely due to differences in practice style or ‘medical discretion’; 5–10=high variation; >10=very high variation.
*Very high variation.
†High variation.
CoV, coefficient of variation; EQ, extreme quotient; IqR, interquartile ratio; SCV, systematic component of variation.
Figure 3Relationships between referral rates, in-hospital surgical rates and regional surgical rates.
Between-hospital variation in crude average costs per patient
| Mean† | Percentage of total cost | Min–max‡ | P25–P75 | P value§ | |
| Non-surgically treated patients (n=43 821) | |||||
| Treatment | 3 | 2 | 0–16 | 1–4 | 0.11 |
| Consultations | 120 | 79 | 104–131 | 113–124 | 0.02* |
| Diagnostics | 22 | 13 | 1–20 | 7–12 | 0.01* |
| Hospitalisation | 8 | 6 | 1–49 | 10–27 | 0.04* |
| Total cost | 153 | 100 | 123–188 | 140–159 | 0.02* |
| Adenoidectomy patients (n=3628) | |||||
| Treatment | 244 | 30 | 203–287 | 218–240 | 0.16 |
| Consultations | 135 | 17 | 102–180 | 123–146 | 0.03* |
| Diagnostics | 20 | 2 | 3–38 | 11–19 | 0.02* |
| Hospitalisation | 416 | 51 | 370–525 | 395–420 | 0.06* |
| Total cost | 814 | 100 | 716–910 | 758–820 | 0.13 |
| Adenotonsillectomy patients (n=14 615) | |||||
| Treatment | 474 | 44 | 388–799 | 409–507 | 0.01* |
| Consultations | 132 | 12 | 103–172 | 123–141 | 0.01* |
| Diagnostics | 8 | 1 | 0–26 | 4–11 | 0.01* |
| Hospitalisation | 455 | 43 | 411–658 | 431–472 | 0.02* |
| Total cost | 1070 | 100 | 927–1343 | 1003–1128 | 0.01* |
| Ventilation tube patients (n=27 086) | |||||
| Treatment | 355 | 38 | 221–406 | 290–378 | 0.01* |
| Consultations | 167 | 18 | 132–208 | 155–175 | 0.01* |
| Diagnostics | 22 | 2 | 3–64 | 10–27 | 0.01* |
| Hospitalisation | 396 | 42 | 282–491 | 388–420 | 0.01* |
| Total cost | 940 | 100 | 709–1058 | 891–975 | 0.01* |
*Statistically significant.
†Patient level.
‡Variation in crude average costs between 14 hospitals.
§Tests homogeneity between hospitals using a generalised linear mixed effects model to adjust costs for age, socioeconomic status and Charlson Comorbidity Index.